BIOEN vs A1CAP Comparison
Price, market cap, valuation, profitability and leverage metrics of BIOEN and A1CAP side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | BIOEN | A1CAP | Sector median |
|---|---|---|---|
| Last price (TL) | 9.20 | 4.24 | 20.38 |
| Daily change | −9.80% | −4.29% | −5.53% |
| Market cap | TRY 4.6B | TRY 2.9B | TRY 10.8B |
| P/E | — | 1.76 | 14.38 |
| P/B | 1.56 | 0.33 | 1.09 |
| Return on equity | −23.95% | 21.79% | 4.43% |
| Free float | 52.11% | 33.94% | 26.02% |
Popular comparisons
Related pages
About the BIOEN vs A1CAP comparison
Price, market cap, valuation multiples, profitability and leverage of BIOEN (Biotrend Cevre ve Enerji) and A1CAP (A1 Capital Yatirim) side by side as of Sep 28, 2026, 11:05. Of the 14 metrics compared, BIOEN leads in 3 and A1CAP leads in 11.
Highlights: Daily change: A1CAP leads (−4.29% vs −9.80%). Market cap: BIOEN leads (TRY 4.6B vs TRY 2.9B). P/B: A1CAP leads (0.33 vs 1.56). EV/EBITDA: BIOEN leads (85.99 vs −2.21). EV/Sales: BIOEN leads (7.58 vs −0.78). Gross margin: A1CAP leads (6.40% vs −7.36%). EBITDA margin (annual): A1CAP leads (15.49% vs 5.02%). Net margin (annual): A1CAP leads (5.16% vs −34.61%).
Frequently asked questions
Is BIOEN or A1CAP cheaper?
By P/E, Tie is cheaper (— vs 1.76); by P/B, A1CAP trades at the lower multiple (1.56 vs 0.33).
Which is more profitable, BIOEN or A1CAP?
Annual net margin is −34.61% for BIOEN and 5.16% for A1CAP; return on equity is −23.95% for BIOEN and 21.79% for A1CAP.
Which is more leveraged, BIOEN or A1CAP?
The leverage ratio is 71.76 for BIOEN and 67.81 for A1CAP; net debt/EBITDA is 46.35 for BIOEN and −2.70 for A1CAP. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.